NCT00646555View on ClinicalTrials.gov

Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

November 20, 2003

Study Completion Date

April 10, 2012

Conditions
Breast Neoplasms
Trial Locations (1)

20037

GW University Medical Center GW Hospital Center, Washington D.C.

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00646555 - Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis | Biotech Hunter | Biotech Hunter